Pédiatrie Tumeurs solides
METRO-PD1-1708
Metro-PD1: a phase I/II trial evaluating anti-PD1 (Nivolumab) in combination with metronomic chemotherapy in children and teenagers with refractory /relapsing solid tumors or lymphoma
Paris
ISABELLE AERTS